Markus Muschen
Institution Name:
Children's Hospital of Los Angeles
Total Awards:
1
Award Value:
$850,769
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Early Translational II | Children's Hospital of Los Angeles | Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication | $850,769 |
Total: $850,769.00 |
Publications
- Nature 2011 BCL6 enables Ph(+) acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. (PubMed: 21593872)
- J Exp Med 2011 BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. (PubMed: 21911423)
- Blood 2011 Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. (PubMed: 21856866)
- Blood 2012 Zebrafish screen identifies novel compound with selective toxicity against leukemia. (PubMed: 22490804)
- Immunity 2011 Control of B cell development by the histone H2A deubiquitinase MYSM1. (PubMed: 22169041)